These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 22378061)

  • 1. Chronic inflammation, immune escape, and oncogenesis in the liver: a unique neighborhood for novel intersections.
    Stauffer JK; Scarzello AJ; Jiang Q; Wiltrout RH
    Hepatology; 2012 Oct; 56(4):1567-74. PubMed ID: 22378061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The progression of non-A, non-B hepatitis to chronic diseases, and the transformation to hepatocellular carcinoma].
    Ichida T; Ichida F
    Nihon Rinsho; 1988 Dec; 46(12):2669-75. PubMed ID: 2853799
    [No Abstract]   [Full Text] [Related]  

  • 3. Nucleic Acid-Induced Signaling in Chronic Viral Liver Disease.
    Roca Suarez AA; Testoni B; Baumert TF; Lupberger J
    Front Immunol; 2020; 11():624034. PubMed ID: 33613561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The natural course of hepatitis B and hepatitis C virus infection].
    Schwabe RF; Stremmel W
    Praxis (Bern 1994); 1998 Oct; 87(42):1403-7. PubMed ID: 9824947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of insulin-like growth factor II in hepatitis B, cirrhosis and hepatocellular carcinoma: its relationship with hepatitis B virus antigen expression.
    Su Q; Liu YF; Zhang JF; Zhang SX; Li DF; Yang JJ
    Hepatology; 1994 Oct; 20(4 Pt 1):788-99. PubMed ID: 7927218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PNPLA3 I148M polymorphism and progressive liver disease.
    Dongiovanni P; Donati B; Fares R; Lombardi R; Mancina RM; Romeo S; Valenti L
    World J Gastroenterol; 2013 Nov; 19(41):6969-78. PubMed ID: 24222941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of membrane cofactor protein (MCP, CD46) in human liver diseases.
    Kinugasa N; Higashi T; Nouso K; Nakatsukasa H; Kobayashi Y; Ishizaki M; Toshikuni N; Yoshida K; Uematsu S; Tsuji T
    Br J Cancer; 1999 Aug; 80(11):1820-5. PubMed ID: 10468303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liver cell dysplasia and hepatocellular carcinoma in non-A, non-B hepatitis.
    Lefkowitch JH; Apfelbaum TF
    Arch Pathol Lab Med; 1987 Feb; 111(2):170-3. PubMed ID: 3028314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic association of interleukin-6 polymorphism (-174 G/C) with chronic liver diseases and hepatocellular carcinoma.
    Giannitrapani L; Soresi M; Balasus D; Licata A; Montalto G
    World J Gastroenterol; 2013 Apr; 19(16):2449-55. PubMed ID: 23674845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aberrant composition of the dendritic cell population in hepatic lymph nodes of patients with hepatocellular carcinoma.
    Tang TJ; Vukosavljevic D; Janssen HL; Binda RS; Mancham S; Tilanus HW; Ijzermans JN; Drexhage H; Kwekkeboom J
    Hum Pathol; 2006 Mar; 37(3):332-8. PubMed ID: 16613328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Viral hepatitis, inflammation, and cancer: A lesson for autoimmunity.
    Piconese S; Cammarata I; Barnaba V
    J Autoimmun; 2018 Dec; 95():58-68. PubMed ID: 30509387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of interferon alpha/beta receptor in human hepatocellular carcinoma.
    Kondo M; Nagano H; Sakon M; Yamamoto H; Morimoto O; Arai I; Miyamoto A; Eguchi H; Dono K; Nakamori S; Umeshita K; Wakasa K; Ohmoto Y; Monden M
    Int J Oncol; 2000 Jul; 17(1):83-8. PubMed ID: 10853022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-28B rs12979860 C/T allele distribution in patients with liver cirrhosis: role in the course of chronic viral hepatitis and the development of HCC.
    Fabris C; Falleti E; Cussigh A; Bitetto D; Fontanini E; Bignulin S; Cmet S; Fornasiere E; Fumolo E; Fangazio S; Cerutti A; Minisini R; Pirisi M; Toniutto P
    J Hepatol; 2011 Apr; 54(4):716-22. PubMed ID: 21146242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of interleukin-17 associated with disease progression and liver fibrosis with hepatitis B virus infection: IL-17 in HBV infection.
    Du WJ; Zhen JH; Zeng ZQ; Zheng ZM; Xu Y; Qin LY; Chen SJ
    Diagn Pathol; 2013 Feb; 8():40. PubMed ID: 23448394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of antibodies to hepatitis C virus in Spanish patients with hepatocellular carcinoma and hepatic cirrhosis.
    Bruix J; Barrera JM; Calvet X; Ercilla G; Costa J; Sanchez-Tapias JM; Ventura M; Vall M; Bruguera M; Bru C
    Lancet; 1989 Oct; 2(8670):1004-6. PubMed ID: 2572739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatocellular carcinoma and chronic persistent hepatitis.
    Shikata T; Yamazaki S; Uzawa T
    Acta Pathol Jpn; 1977 May; 27(3):297-304. PubMed ID: 200057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Detection of alpha-interferon positive cells in liver tissue from patients with hepatitis].
    Jing XF
    Zhonghua Bing Li Xue Za Zhi; 1993 Feb; 22(1):22-4. PubMed ID: 8392441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the natural history of alcoholic and nonalcoholic fatty liver disease.
    Mills SJ; Harrison SA
    Curr Gastroenterol Rep; 2005 Feb; 7(1):32-6. PubMed ID: 15701296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune response involved in liver damage and the activation of hepatic progenitor cells during liver tumorigenesis.
    Hou XJ; Ye F; Li XY; Liu WT; Jing YY; Han ZP; Wei LX
    Cell Immunol; 2018 Apr; 326():52-59. PubMed ID: 28860007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. KIR content genotypes associate with carriage of hepatitis B surface antigen, e antigen and HBV viral load in Gambians.
    Yindom LM; Mendy M; Bodimeade C; Chambion C; Aka P; Whittle HC; Rowland-Jones SL; Walton R
    PLoS One; 2017; 12(11):e0188307. PubMed ID: 29149205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.